Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Adenocarcinoma
Neoadjuvant chemotherapy followed by CRT compared to chemotherapy alone for resected BD and LA PDAC was demonstrated to significantly improve median OS, in particular, in patients with R1 resection margins, ypN1 nodal status, and perivascular invasion.
Authors
- Sacheen Kumar (ORCID: https://orcid.org/0000-0002-4692-4554)
- Kai Tai Derek Yeung (ORCID: https://orcid.org/0000-0002-5679-9435)
- David Cunningham (ORCID: https://orcid.org/0000-0001-5158-1069)
- Ricky H. Bhogal (ORCID: https://orcid.org/0000-0002-5053-7979)
- Long R. Jiao (ORCID: https://orcid.org/0000-0001-6774-4280)
Institutions
- Royal Marsden Hospital (GB)
- Imperial College London (GB)
Publication Details
- Journal
- Annals of Surgery Open
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1097/as9.0000000000000486
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00